Translational Research to Raise the Bar for the Development of Psychedelic-Based Medicines

Time: 4:45 pm
day: Day One


• Evaluating the receptors that we are targeting at Psilera and our approaches to repurposing psychoactive natural products as building blocks for next generation therapies to improve mental health • Targeting patient-friendly, non-invasive delivery forms for psychedelics with poor oral bioavailability
• Assessing serotonin receptor activation of psychedelic drugs and novel analogues to accelerate and further validate our drug pipeline